| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $43K | -98.4% |
| Cost of Revenue | $5K | -99.5% |
| Gross Profit | $38K | -97.6% |
| R&D Expense | $236K | +2.6% |
| SG&A Expense | $694K | -93.0% |
| Operating Income | -$735K | +91.4% |
| Net Income | $485K | +105.6% |
| EPS (Basic) | $0.01 | +106.7% |
| EPS (Diluted) | $0.01 | +106.7% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108K | +0.9% |
| Accounts Receivable | $541K | +475.5% |
| Current Assets | $1.6M | +396.2% |
| Total Assets | $2.3M | +317.0% |
| Current Liabilities | $3.8M | +54.5% |
| Total Liabilities | $4.2M | +7.6% |
| Stockholders' Equity | -$1.9M | +44.2% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $531K | +268.6% |
| Capital Expenditures | $8K | -92.1% |
| Investing Cash Flow | -$1.3M | -1190.1% |
| Financing Cash Flow | $773K | +158.5% |
| Free Cash Flow | $523K | +225.7% |